Przegląd Dermatologiczny

Abstract

6/2018 vol. 105
Case report

Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®)

Dermatol Rev/Przegl Dermatol 2018, 105, 753–760
Online publish date: 2019/01/04
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Octenisept® is an antiseptic solution which is intended to be applied on the skin, mucous membranes and wounds.

Objective

To present a case study of a bullous skin lesions, which occurred in a 4-year-old girl after Octenisept® application, and to highlight various possible side effects of this preparation.

Case report

In a 4-year-old girl Octenisept® was applied preventively three times at intervals of 12 hours on an epidermal abrasion. Erythema and hydropic papules emerged 6–8 hours after application and were followed by vesicles and bullae 8 hours later. In spite of the topical treatment with glucocorticoids and an antibiotic, the lesions persisted for several weeks.

Conclusions

Taking into consideration the wide usage of Octenisept® in many fields of medicine, there is a need to conduct further research on the allergic potential and toxicity of this product.

Share
without publication fees
without publication fees